These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 34830348)
1. Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders. Padilla-Godínez FJ; Ramos-Acevedo R; Martínez-Becerril HA; Bernal-Conde LD; Garrido-Figueroa JF; Hiriart M; Hernández-López A; Argüero-Sánchez R; Callea F; Guerra-Crespo M Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830348 [TBL] [Abstract][Full Text] [Related]
2. Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases. Callea F; Francalanci P; Giovannoni I Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071368 [TBL] [Abstract][Full Text] [Related]
3. Autophagy-enhancing drug carbamazepine diminishes hepatocellular death in fibrinogen storage disease. Puls F; Goldschmidt I; Bantel H; Agne C; Bröcker V; Dämmrich M; Lehmann U; Berrang J; Pfister ED; Kreipe HH; Baumann U J Hepatol; 2013 Sep; 59(3):626-30. PubMed ID: 23707368 [TBL] [Abstract][Full Text] [Related]
4. The Recruitment-Secretory Block ("R-SB") Phenomenon and Endoplasmic Reticulum Storage Diseases. Callea F; Tomà P; Bellacchio E Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202771 [TBL] [Abstract][Full Text] [Related]
5. Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking. Stojkovska I; Wani WY; Zunke F; Belur NR; Pavlenko EA; Mwenda N; Sharma K; Francelle L; Mazzulli JR Neuron; 2022 Feb; 110(3):436-451.e11. PubMed ID: 34793693 [TBL] [Abstract][Full Text] [Related]
6. The Autophagy Pathway: A Critical Route in the Disposal of Alpha 1-Antitrypsin Aggregates That Holds Many Mysteries. Leon C; Bouchecareilh M Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668611 [TBL] [Abstract][Full Text] [Related]
7. Multiple Genes Core to ERAD, Macroautophagy and Lysosomal Degradation Pathways Participate in the Proteostasis Response in α1-Antitrypsin Deficiency. Li J; Moretti F; Hidvegi T; Sviben S; Fitzpatrick JAJ; Sundaramoorthi H; Pak SC; Silverman GA; Knapp B; Filipuzzi I; Alford J; Reece-Hoyes J; Nigsch F; Murphy LO; Nyfeler B; Perlmutter DH Cell Mol Gastroenterol Hepatol; 2024; 17(6):1007-1024. PubMed ID: 38336172 [TBL] [Abstract][Full Text] [Related]
8. The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease. Khodayari N; Wang RL; Oshins R; Lu Y; Millett M; Aranyos AM; Mostofizadeh S; Scindia Y; Flagg TO; Brantly M Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948056 [TBL] [Abstract][Full Text] [Related]
9. Hereditary Hypofibrinogenemia with Hepatic Storage. Asselta R; Paraboschi EM; Duga S Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105716 [TBL] [Abstract][Full Text] [Related]
10. Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum. Melo TQ; Copray SJCVM; Ferrari MFR Neurochem Res; 2018 Dec; 43(12):2212-2223. PubMed ID: 30370500 [TBL] [Abstract][Full Text] [Related]
11. The molecular and cellular pathology of α₁-antitrypsin deficiency. Gooptu B; Dickens JA; Lomas DA Trends Mol Med; 2014 Feb; 20(2):116-27. PubMed ID: 24374162 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of misfolding and conformational change in α1-antitrypsin deficiency. Nyon MP; Gooptu B Future Med Chem; 2014 Jun; 6(9):1047-65. PubMed ID: 25068987 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of Parkinson's disease: emerging role of molecular chaperones. Bandopadhyay R; de Belleroche J Trends Mol Med; 2010 Jan; 16(1):27-36. PubMed ID: 20036196 [TBL] [Abstract][Full Text] [Related]
14. New Concepts in Alpha-1 Antitrypsin Deficiency Disease Mechanisms. Marciniak SJ; Ordóñez A; Dickens JA; Chambers JE; Patel V; Dominicus CS; Malzer E Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S289-96. PubMed ID: 27564663 [TBL] [Abstract][Full Text] [Related]
15. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis. Mehra S; Sahay S; Maji SK Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581 [TBL] [Abstract][Full Text] [Related]
16. Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease. Kruse KB; Dear A; Kaltenbrun ER; Crum BE; George PM; Brennan SO; McCracken AA Am J Pathol; 2006 Apr; 168(4):1299-308; quiz 1404-5. PubMed ID: 16565503 [TBL] [Abstract][Full Text] [Related]
17. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Hidvegi T; Ewing M; Hale P; Dippold C; Beckett C; Kemp C; Maurice N; Mukherjee A; Goldbach C; Watkins S; Michalopoulos G; Perlmutter DH Science; 2010 Jul; 329(5988):229-32. PubMed ID: 20522742 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Excessive Oxidative Protein Folding Is Protective in MPP(+) Toxicity-Induced Parkinson's Disease Models. Lehtonen Š; Jaronen M; Vehviläinen P; Lakso M; Rudgalvyte M; Keksa-Goldsteine V; Wong G; Courtney MJ; Koistinaho J; Goldsteins G Antioxid Redox Signal; 2016 Sep; 25(8):485-97. PubMed ID: 27139804 [TBL] [Abstract][Full Text] [Related]
19. Sirtuin3 promotes the degradation of hepatic Z alpha-1 antitrypsin through lipophagy. Poole B; Oshins R; Huo Z; Aranyos A; West J; Duarte S; Clark VC; Beduschi T; Zarrinpar A; Brantly M; Khodayari N Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285890 [TBL] [Abstract][Full Text] [Related]
20. Protein misfolding and aggregation in Parkinson's disease. Tan JM; Wong ES; Lim KL Antioxid Redox Signal; 2009 Sep; 11(9):2119-34. PubMed ID: 19243238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]